Canopy Growth Corp's stock saw a significant rise after the company reported strong revenue growth and reduced losses.
In yesterday's trading session, Canopy Growth Corp (WEED.TO) saw its stock price increase by 5.30%, closing at CA$1.39. This jump follows the company’s recent quarterly results, which highlighted solid performance across its cannabis segments.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeMarket cap
$661.03M
52W high
$3.28
52W low
$1.18
1W change
-4.14%
Beta
2.41
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 45.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+45.3% Upside
Current Price
C$1.39
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
39.8%
Annualized
90-Day Vol
58.0%
Annualized
Trend (90d)
-32.0%
Annualized drift
90d Mean
C$1.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.34 | C$1.17 – C$1.54 |
| 60 trading days | C$1.29 | C$1.06 – C$1.56 |
| 90 trading days | C$1.24 | C$0.98 – C$1.57 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are reacting positively to Canopy's focus on cultivation and cost management, leading to better financial metrics and a decrease in losses.
5.30% Surge in Stock Price
Canopy Growth's stock gained 5.30% yesterday, reflecting investor optimism after a strong earnings report.
Bull case
The company reported a 13% year-over-year revenue growth, particularly in the medical cannabis segment, indicating a possible turnaround for Canopy Growth as it continues to implement its strategic plans.
Bear case
Despite the positive results, Canopy still faces challenges, including significant cash outflows and ongoing pressures from changes in reimbursement rates for medical cannabis.
Strong Quarterly Performance
Advertisement
Canopy Growth reported a 13% increase in net revenue for the first quarter of fiscal 2027, totaling CA$81.2 million. This growth was driven by a 22% increase in medical cannabis revenue and a 10% rise in adult-use cannabis sales, showcasing the company's ability to meet market demand.
Strategic Focus on Cost Management
The company’s efforts to streamline operations and manage costs effectively have led to a 68% reduction in net losses year-over-year. Canopy's management noted that integrating MTL Cannabis is expected to create more revenue opportunities and operational synergies moving forward.
Market Reactions and Future Outlook
The positive market reaction to Canopy's quarterly results suggests that investors are hopeful about the company's future. However, ongoing challenges, such as cash outflows and regulatory pressures, will need to be watched closely as Canopy navigates the changing cannabis landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
